174 related articles for article (PubMed ID: 36721527)
1. Serum YKL-40 Levels and White Matter Hyperintensities in Patients with Acute Ischemic Stroke.
Shi G; Ke D; Gong P; Yu P; Zhou J; Wang M; Zhang X; Wang X; Guo M; Xu M; Zhou R
J Inflamm Res; 2023; 16():311-319. PubMed ID: 36721527
[TBL] [Abstract][Full Text] [Related]
2. Gut-Derived Metabolite Phenylacetylglutamine and White Matter Hyperintensities in Patients With Acute Ischemic Stroke.
Yu F; Feng X; Li X; Luo Y; Wei M; Zhao T; Xia J
Front Aging Neurosci; 2021; 13():675158. PubMed ID: 34393756
[No Abstract] [Full Text] [Related]
3. Correlation between body composition and white matter hyperintensity in patients with acute ischemic stroke.
Wu B; Huang D; Yi Z; Yu F; Liu L; Tang X; Jing K; Fan J; Pan C
Medicine (Baltimore); 2023 Dec; 102(50):e36497. PubMed ID: 38115357
[TBL] [Abstract][Full Text] [Related]
4. Association of deep white matter hyperintensity with left ventricular hypertrophy in acute ischemic stroke.
Nagaraja N; Farooqui A; Albayram MS
J Neuroimaging; 2022 Mar; 32(2):268-272. PubMed ID: 34861077
[TBL] [Abstract][Full Text] [Related]
5. White Matter Hyperintensity, Immediate Antihypertensive Treatment, and Functional Outcome After Acute Ischemic Stroke.
Zhu S; Qian S; Xu T; Peng H; Dong R; Wang D; Yuan X; Guo L; Zhang Y; Geng D; Zhong C
Stroke; 2020 May; 51(5):1608-1612. PubMed ID: 32233741
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in the correlation between white matter hyperintensity and 3-month outcome in acute stroke patients.
Ren J; Zhang X; Xie H; Zhou X; Xu J; Qiu H; Zhou J; Xie W; Chen S; Lu X; Fan Y; Yang D; Chen G
Heliyon; 2024 May; 10(9):e30190. PubMed ID: 38707361
[TBL] [Abstract][Full Text] [Related]
7. Association between Serum Amyloid A Level and White Matter Hyperintensity Burden: a Cross-Sectional Analysis in Patients with Acute Ischemic Stroke.
Zhang P; Han R; Zhang A; Zhang X; Zhang Z; Yu H; Li H; Qi Z; Xu P; Yang P; Li D
Neurol Ther; 2023 Feb; 12(1):161-175. PubMed ID: 36374429
[TBL] [Abstract][Full Text] [Related]
8. Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?
Pradeep A; Raghavan S; Przybelski SA; Preboske G; Schwarz CG; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Graff-Radford J; Cogswell PM; Vemuri P
Res Sq; 2024 Mar; ():. PubMed ID: 38558965
[TBL] [Abstract][Full Text] [Related]
9. Relationship between white matter hyperintensities and chronic kidney disease in patients with acute lacunar stroke.
Yang L; Yu L; Kong Y; Zhang X; Li Y; Yang S; Gu H; Gao S; Hu W
Neurol Sci; 2020 Nov; 41(11):3307-3313. PubMed ID: 32417986
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of White Matter Hyperintensity and Cognitive Impairment in Patients with Acute Lacunar Stroke.
Ye M; Zhou Y; Chen H; Zhu S; Diao S; Zhao J; Kong Y; Li T
Brain Sci; 2022 Dec; 12(12):. PubMed ID: 36552134
[TBL] [Abstract][Full Text] [Related]
11. Association of Plasma Lipids with White Matter Hyperintensities in Patients with Acute Ischemic Stroke.
Liu Y; Yuan C; Chen X; Fang X; Hao J; Zhou M; Sun X; Wu M; Wang Z
Int J Gen Med; 2023; 16():5405-5415. PubMed ID: 38021054
[TBL] [Abstract][Full Text] [Related]
12. Higher High-Mobility Group Box-1 Levels are Associated with White Matter Lesions in Ischemic Stroke Patients.
Zhao J; Xu F; Xu W; Lv R; Wang J; Yang X
J Inflamm Res; 2023; 16():4441-4449. PubMed ID: 37842188
[TBL] [Abstract][Full Text] [Related]
13. Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study.
Chappell FM; Del Carmen Valdés Hernández M; Makin SD; Shuler K; Sakka E; Dennis MS; Armitage PA; Muñoz Maniega S; Wardlaw JM
Trials; 2017 Feb; 18(1):78. PubMed ID: 28222778
[TBL] [Abstract][Full Text] [Related]
14. White matter hyperintensities and recurrent stroke risk in patients with stroke with small-vessel disease.
Park JH; Heo SH; Lee MH; Kwon HS; Kwon SU; Lee JS;
Eur J Neurol; 2019 Jun; 26(6):911-918. PubMed ID: 30637882
[TBL] [Abstract][Full Text] [Related]
15. Risk factors analysis according to regional distribution of white matter hyperintensities in a stroke cohort.
Medrano-Martorell S; Capellades J; Jiménez-Conde J; González-Ortiz S; Vilas-González M; Rodríguez-Campello A; Ois Á; Cuadrado-Godia E; Avellaneda C; Fernández I; Merino-Peña E; Roquer J; Martí-Fàbregas J; Giralt-Steinhauer E
Eur Radiol; 2022 Jan; 32(1):272-280. PubMed ID: 34117555
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia can predict the severity of white matter hyperintensities in elderly lacunar infarction patients.
Yu L; Yang L; Li Y; Yang S; Gu H; Hu W; Gao S
Int J Neurosci; 2020 Mar; 130(3):231-236. PubMed ID: 31744348
[No Abstract] [Full Text] [Related]
17. Association between H-type Hypertension and White Matter Hyperintensity in Patients with Acute Ischemic Stroke.
Yang J; Cao Z; Jiang J; Zhou Y; Zhu X
Curr Neurovasc Res; 2023; 20(2):190-196. PubMed ID: 37221694
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine Level Is Associated with White Matter Hyperintensity Locations in Patients with Acute Ischemic Stroke.
Gao Y; Wei S; Song B; Qin J; Fang H; Ji Y; Zhang R; Sun S; Xu Y
PLoS One; 2015; 10(12):e0144431. PubMed ID: 26641086
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of white matter hyperintensities on long-term outcomes in ischemic stroke patients with large artery atherosclerosis.
Baik M; Kim K; Yoo J; Kim HC; Jeong SH; Kim KH; Park HJ; Kim YD; Heo JH; Nam HS
PLoS One; 2017; 12(12):e0189611. PubMed ID: 29232701
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory profile and white matter hyperintensity burden in acute ischemic stroke patients.
Rascle L; Nighoghossian N; Cho TH; Bochaton T; Paccalet A; Crola Da Silva C; Buisson M; Amaz C; Fontaine J; Ong E; Derex L; Berthezene Y; Eker OF; Mewton N; Ovize M; Mechtouff L
J Neuroimmunol; 2022 Oct; 371():577934. PubMed ID: 35961224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
